8.3312
Avantor Inc stock is traded at $8.3312, with a volume of 10.49M.
It is up +0.30% in the last 24 hours and up +4.19% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$8.31
Open:
$8.32
24h Volume:
10.49M
Relative Volume:
1.01
Market Cap:
$5.68B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-10.31
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+4.71%
1M Performance:
+4.19%
6M Performance:
-27.84%
1Y Performance:
-32.13%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
8.325 | 5.67B | 6.55B | -551.40M | 438.90M | -0.8082 |
|
ISRG
Intuitive Surgical Inc
|
450.57 | 160.61B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
148.45 | 43.60B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
39.63 | 35.40B | 29.14B | 1.07B | 1.52B | 1.1995 |
|
ALC
Alcon Inc
|
62.60 | 31.15B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
206.77 | 30.01B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor forecasts Q2 adjusted EPS of $0.19-$0.20 while incorporating $10M-$20M inflation headwind - MSN
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Avantor Reports Lower Q1 Profit, Reaffirms 2026 Guidance - MyChesCo
Avantor expands Masterflex portfolio to streamline bioprocessing - MSN
5 Must-Read Analyst Questions From Avantor’s Q1 Earnings Call - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor director Simon Dingemans buys $203,500 in company stock - Investing.com
Avantor (AVTR) director adds 25,000 shares via open-market purchase - Stock Titan
Avantor (NYSE: AVTR) EVP Ludovic Brellier awarded RSUs and 246,002 stock options - Stock Titan
Avantor (NYSE: AVTR) EVP files initial Form 3 ownership - Stock Titan
Superdisintegrants Market registering a CAGR of 7.60% during - openPR.com
Avantor, Inc. (AVTR) Stock Analysis: Navigating a Complex Landscape with a 24.66% Potential Upside - DirectorsTalk Interviews
Avantor, Inc. (AVTR) Q1 earnings and revenues top estimates - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Shareholders to Connect - ACCESS Newswire
How The Avantor (AVTR) Narrative Is Shifting After Valuation Reset And Execution Concerns - Yahoo Finance
Avantor shares jump 9% after Q1 earnings beat - MSN
Avantor Names Ludovic Brellier EVP of BMP and Chief Transformation Officer - MyChesCo
Avantor (NYSE:AVTR) Upgraded to Hold at Zacks Research - MarketBeat
Avantor CFO Brent Jones Resigns Amid Corporate Turnaround Program - HarianBasis.co
Avantor Inc (AVTR) Stock Price, Quote, News & History - Benzinga
Yacktman Asset Management's Avantor Inc(AVTR) Holding History - GuruFocus
Stifel Maintains Avantor(AVTR.US) With Hold Rating, Cuts Target Price to $8 - Moomoo
Barclays Reaffirms Their Sell Rating on Avantor (AVTR) - The Globe and Mail
MSN Money - MSN
Avantor Shares Surge After Beating First Quarter Financial Estimates - HarianBasis.co
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
William Blair Keeps Market Perform Rating on Avantor (AVTR) After CFO Departure - Insider Monkey
Citigroup Cuts Avantor (NYSE:AVTR) Price Target to $9.00 - MarketBeat
Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible - Seeking Alpha
Precision Trading with Avantor Inc. (AVTR) Risk Zones - Stock Traders Daily
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline - Yahoo Finance
Avantor stock up as new lab capabilities improve biopharma support - MSN
Avantor Expands Masterflex Brand Across Fluid Handling Portfolio - MyChesCo
Avantor, Inc. (NYSE:AVTR) Q1 2026 Earnings Call Transcript - Insider Monkey
Avantor Q1 2026 earnings preview - MSN
Avantor Q1 2026 slides show turnaround progress, stock surges 10% By Investing.com - Investing.com Australia
AVTR Q1 Deep Dive: Leadership Changes, Segment Stabilization, and Execution Drive Outlook - The Globe and Mail
Avantor Q1 Earnings Call Highlights - Yahoo Finance
Avantor Reports "Turning Point" in Q1 2026 as Revival Transformation Begins to Deliver - Lab Manager
Vanguard holds 35.8M shares of Avantor (AVTR) in Schedule 13G - Stock Titan
Avantor (NYSE:AVTR) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Avantor projects organic revenue growth of negative 2.5% to negative 0.5% for 2026 amid revival program and business resegmentation - MSN
Avantor, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Avantor, Inc. Q1 2026 Financial Results, Risk Factors, and Forward-Looking Statements – SEC Form 10-Q Highlights - Minichart
Avantor (NYSE:AVTR) Shares Gap Up on Strong Earnings - MarketBeat
Avantor Q1 2026 slides show turnaround progress, stock surges 10% - Investing.com
Avantor® Reports First Quarter 2026 Results - GuruFocus
Earnings call transcript: Avantor Q1 2026 beats expectations, stock surges By Investing.com - Investing.com Australia
Earnings call transcript: Avantor Q1 2026 beats expectations, stock surges - Investing.com
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):